"A sua principal missão é promover a investigação clínica, fornecendo o apoio necessário e procurando garantir que os resultados se traduzam em benefícios para os pacientes. As infraestruturas à disposição dos diferentes parceiros, bem como a proximidade entre os mesmos, criam as condições ideais para que a investigação se alie à prática clínica, maximizando o desenvolvimento de biomateriais, estratégias de diagnóstico, abordagens regenerativas e produtos terapêuticos. O 2CA-Braga procura fortalecer a posição da Escola de Medicina da Universidade do Minho como líder em inovação em biociência e investigação translacional. Paralelamente, pretende contribuir para a preservação da saúde da população e para a melhoria da sua qualidade de vida,"

During the past decade, Centro Clinico Academico - Braga conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Clinico Academico - Braga" #1 sponsor was "Bayer" with 5 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Clinico Academico - Braga" #1 collaborator was "Connect for Children" with 1 trials as a collaborator, "European Fundation for the Care of the Newborn Infants" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "PARTNERS for International clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Centro Clinico Academico - Braga" are "Arthritis, Psoriatic" (2 trials), "Acetaminophen" (1 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials) and "Extreme Prematurity" (1 trials). Many other conditions were trialed in "Centro Clinico Academico - Braga" in a lesser frequency.

Most popular intervention types in "Centro Clinico Academico - Braga" are "Drug" (11 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Guselkumab" (2 trials), "Acetaminophen" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Clinico Academico - Braga" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Clinico Academico - Braga". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro Clinico Academico - Braga, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Clinico Academico - Braga, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".